Clinical-pathological features and prognosis of thrombotic thrombocytopenic purpura in patients with lupus nephritis

American Journal of the Medical Sciences

Volumn 338, Issue 5, 2009, Pages 343-347

  Zheng, Tang ^a,b   Chunlei, Luo ^b   Zhen, Wang ^b   Ping, Liu ^b   Haitao, Zhang ^a,b   Weixin, Hu ^a,b   Caihong, Zeng ^a,b   Huiping, Chen ^a,b   Zhihong, Liu ^a,b   Leishi, Li ^a,b  

^a JINLING HOSPITAL   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

Clinical pathological features; Lupus nephritis; Prognosis; Thrombotic thrombocytopenic purpura

Indexed keywords

ANTINUCLEAR ANTIBODY; CARDIOLIPIN ANTIBODY; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; DOUBLE STRANDED DNA ANTIBODY; ENDOTHELIAL CELL ANTIBODY; HEMOGLOBIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LACTATE DEHYDROGENASE; NEUTROPHIL CYTOPLASMIC ANTIBODY; POTASSIUM; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPLEMENT BLOOD LEVEL; ENZYME BLOOD LEVEL; FATALITY; FEMALE; FOCAL GLOMERULOSCLEROSIS; FOLLOW UP; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HISTOLOGY; HUMAN; IMMUNOADSORPTION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY NECROSIS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; PERITONEAL DIALYSIS; PLASMAPHERESIS; POTASSIUM BLOOD LEVEL; PROGNOSIS; PROTEIN BLOOD LEVEL; RETICULOCYTE COUNT; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 73649143907     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181b0c872     Document Type: Article

References (27)

1. Desch KC, Motto DG. Thrombotic thrombocytopenic purpura in humans and mice. Arterioscler Thromb Vasc Biol 2007;27:1901-1908
2. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
3. Ridolfi R, Bell W. Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) 1981;60: 413-428
4. Kawasaki Y, Suzuki J, Nozawa R, et al. A 12-year-old girl with hemolytic uremic syndrome as initial symptom of systemic lupus erythematosus and a literature review. Am J Nephrol 2002;22:576-580
5. Chen H, Tang Z, Zeng C, et al. Pathological demography of native patients in a nephrology center in China. Chin Med J (Engl) 2003;116: 1377-1381
6. Matsumoto M, Yagi H, Ishizashi H, et al. The Japanese experience with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Semin Hematol 2004;41:68-74.
7. Bláhová K. [Hemolytic-uremic syndrome]. Vnitr Lek 2004;50:519-525
8. Balow J. Renal vasculitis. Kidney Int 1985;27:954-964
9. Sadler JE, Moake JL, Miyata T, et al. Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004:407-423
10. Patnaik MM, Deshpande AK, Nagar VS, et al. Thrombotic microangiopathies presenting as an obstetric emergency. J Assoc Physicians India 2004;52:152-153
11. Appel G. Renal vascular complications of systemic lupus erythematosus. Am Soc Nephrol 1994;4:1499-1515
12. Bibbo C, Davis W. Foot manifestations of the thrombotic thrombocytopenic purpura hemolytic-uremic syndrome: A review and case report. J Foot Ankle Surg 2005;44:301-306
13. Lämmle B, Kremer Hovinga JA, Alberio L. Thrombotic thrombocytopenic purpura. J Thromb Haemost 2005;3:1663-1675
14. McMahon MA, Keogan M, O'Connell P, et al. The prevalence of antiphospholipid antibody syndrome among systemic lupus erythematosus patients. Ir Med J 2006;99:296-298
15. Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 1997;81:151-177
16. Sakarcan A, Stallworth J. Systemic lupus erythematosus and thrombotic thrombocytopenic purpura: A case and review. Pediatric Nephrol 2001;16:672-674
17. Zhao XZ, Xu CG, Zhang LM, et al. Systemic lupus erythematosus with thrombotic thrombocytopenic purpura: A case and review. Shanghai Med J 2005;28:159-160
18. Ma MX, Yu JR, Wang Y, et al. Systemic lupus erythematosus with thrombotic thrombocytopenic purpura: A case report. Chin J Intern Med 2006;45:269.
19. Franchini M, Zaffanello M, Veneri D. Advances in the pathogenesis, diagnosis and treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Thromb Res 2006;118:177-184
20. Lowe E, Werner E. Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome in children and adolescents. Semin Thromb Hemost 2005;31:717-730
21. Zakarija A, Bennett C. Drug-induced thrombotic microangiopathy. Semin Thromb Hemost 2005;31:681-690
22. Rieger M, Mannucci PM, Kremer Hovinga JA, et al. ADAMTS13 autoantibodies in patients with thrombotic microangiopathies and other immunomediated diseases. Blood 2005;106:1262-1267
23. Tsai HM. Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura. J Am Soc Nephrol 2003;14: 1072-1081
24. Dittman W, Majerus P. Structure and function of thrombomodulin: A natural anticoagulant. Blood 1990;75:329.
25. Rock G, Porta C, Bobbio-Pallavicini E. Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica 2000;85:410-419
26. Leblond PF, Rock G, Herbert CA. The use of plasma as a replacement fluid in plasma exchange. Canadian Apheresis Group. Transfusion 1998;38:834-838
27. Wyllie BF, Garg AX, Macnab J, et al; Members of the Canadian Apheresis Group. Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: A new index predicting response to plasma exchange. Br J Haematol 2006;132:204-209